Literature DB >> 9854056

Comparison of PCR, culture, and serological tests for diagnosis of Mycoplasma pneumoniae respiratory tract infection in children.

J W Dorigo-Zetsma1, S A Zaat, P M Wertheim-van Dillen, L Spanjaard, J Rijntjes, G van Waveren, J S Jensen, A F Angulo, J Dankert.   

Abstract

For diagnosis of Mycoplasma pneumoniae infection we compared two rapid tests, PCR and the immunoglobulin M immunofluorescence assay (IgM IFA), with culture and the complement fixation test (CFT), in a prospective study among 92 children with respiratory tract infection and 74 controls. Based on positivity of culture and/or CFT as the diagnostic criterion, nine patients (10%) were diagnosed with M. pneumoniae infection. All patients positive by culture were also positive by PCR. In all controls cultures, PCRs, and serological assays were negative, except in one with a positive IgM IFA. The IgM IFA had a low positive predictive value of 50%. Only a combination of PCR (seven patients) and CFT (seven patients) allowed diagnosis of all cases.

Entities:  

Mesh:

Year:  1999        PMID: 9854056      PMCID: PMC84154     

Source DB:  PubMed          Journal:  J Clin Microbiol        ISSN: 0095-1137            Impact factor:   5.948


  16 in total

1.  Utility of an internal control for the polymerase chain reaction. Application to detection of Mycoplasma pneumoniae in clinical specimens.

Authors:  J P Ursi; D Ursi; M Ieven; S R Pattyn
Journal:  APMIS       Date:  1992-07       Impact factor: 3.205

2.  Evaluation of Serodia Myco II particle agglutination test for detecting Mycoplasma pneumoniae antibody: comparison with mu-capture ELISA and indirect immunofluorescence.

Authors:  C E Barker; M Sillis; T G Wreghitt
Journal:  J Clin Pathol       Date:  1990-02       Impact factor: 3.411

3.  Enzyme immunoassay for detection of immunoglobulin M (IgM) and IgG antibodies to Mycoplasma pneumoniae.

Authors:  S A Uldum; J S Jensen; J Søndergård-Andersen; K Lind
Journal:  J Clin Microbiol       Date:  1992-05       Impact factor: 5.948

4.  16S rRNA based polymerase chain reaction compared with culture and serological methods for diagnosis of Mycoplasma pneumoniae infection.

Authors:  F J van Kuppeveld; K E Johansson; J M Galama; J Kissing; G Bölske; E Hjelm; J T van der Logt; W J Melchers
Journal:  Eur J Clin Microbiol Infect Dis       Date:  1994-05       Impact factor: 3.267

5.  Detection of Mycoplasma pneumoniae by two polymerase chain reactions and role of M. pneumoniae in acute respiratory tract infections in pediatric patients.

Authors:  M Ieven; D Ursi; H Van Bever; W Quint; H G Niesters; H Goossens
Journal:  J Infect Dis       Date:  1996-06       Impact factor: 5.226

6.  Enhanced isolation of Mycoplasma pneumoniae from throat washings with a newly-modified culture medium.

Authors:  J G Tully; D L Rose; R F Whitcomb; R P Wenzel
Journal:  J Infect Dis       Date:  1979-04       Impact factor: 5.226

Review 7.  Infections caused by Mycoplasma pneumoniae and possible carrier state in different populations of patients.

Authors:  H M Foy
Journal:  Clin Infect Dis       Date:  1993-08       Impact factor: 9.079

Review 8.  Serological diagnosis of Mycoplasma pneumoniae infections: a critical review of current procedures.

Authors:  E Jacobs
Journal:  Clin Infect Dis       Date:  1993-08       Impact factor: 9.079

9.  Detection of Mycoplasma pneumoniae in clinical samples from pediatric patients by polymerase chain reaction.

Authors:  L Skakni; A Sardet; J Just; J Landman-Parker; J Costil; N Moniot-Ville; F Bricout; A Garbarg-Chenon
Journal:  J Clin Microbiol       Date:  1992-10       Impact factor: 5.948

10.  Direct PCR enables detection of Mycoplasma pneumoniae in patients with respiratory tract infections.

Authors:  J H Tjhie; F J van Kuppeveld; R Roosendaal; W J Melchers; R Gordijn; D M MacLaren; J M Walboomers; C J Meijer; A J van den Brule
Journal:  J Clin Microbiol       Date:  1994-01       Impact factor: 5.948

View more
  48 in total

1.  Genotyping of Mycoplasma pneumoniae clinical isolates reveals eight P1 subtypes within two genomic groups.

Authors:  J W Dorigo-Zetsma; J Dankert; S A Zaat
Journal:  J Clin Microbiol       Date:  2000-03       Impact factor: 5.948

2.  Molecular detection of Mycoplasma pneumoniae in adults with community-acquired pneumonia requiring hospitalization.

Authors:  J W Dorigo-Zetsma; R P Verkooyen; H P van Helden; H van der Nat; J M van den Bosch
Journal:  J Clin Microbiol       Date:  2001-03       Impact factor: 5.948

3.  Rapid-cycle PCR for detection and typing of Mycoplasma pneumoniae in clinical specimens.

Authors:  F Kong; S Gordon; G L Gilbert
Journal:  J Clin Microbiol       Date:  2000-11       Impact factor: 5.948

4.  Practice guidelines for the management of community-acquired pneumonia in adults. Infectious Diseases Society of America.

Authors:  J G Bartlett; S F Dowell; L A Mandell; T M File; D M Musher; M J Fine
Journal:  Clin Infect Dis       Date:  2000-09-07       Impact factor: 9.079

5.  Nonculture Laboratory Methods for the Diagnosis of Infectious Endocarditis.

Authors: 
Journal:  Curr Infect Dis Rep       Date:  1999-06       Impact factor: 3.725

Review 6.  Molecular diagnosis of Mycoplasma pneumoniae respiratory tract infections.

Authors:  K Loens; D Ursi; H Goossens; M Ieven
Journal:  J Clin Microbiol       Date:  2003-11       Impact factor: 5.948

7.  Diagnostic utility and clinical significance of naso- and oropharyngeal samples used in a PCR assay to diagnose Mycoplasma pneumoniae infection in children with community-acquired pneumonia.

Authors:  Ian C Michelow; Kurt Olsen; Juanita Lozano; Lynn B Duffy; George H McCracken; R Doug Hardy
Journal:  J Clin Microbiol       Date:  2004-07       Impact factor: 5.948

8.  Mycoplasma pneumoniae in Community-Acquired Lower Respiratory Tract Infections.

Authors:  Surinder Kumar; Indu Bala Garg; Gulshan Rai Sethi
Journal:  Indian J Pediatr       Date:  2018-01-10       Impact factor: 1.967

9.  Evaluation of 12 commercial tests and the complement fixation test for Mycoplasma pneumoniae-specific immunoglobulin G (IgG) and IgM antibodies, with PCR used as the "gold standard".

Authors:  Matthias F C Beersma; Kristien Dirven; Alje P van Dam; Kate E Templeton; Eric C J Claas; Herman Goossens
Journal:  J Clin Microbiol       Date:  2005-05       Impact factor: 5.948

Review 10.  Mycoplasma pneumoniae and its role as a human pathogen.

Authors:  Ken B Waites; Deborah F Talkington
Journal:  Clin Microbiol Rev       Date:  2004-10       Impact factor: 26.132

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.